Mitigating Risk To Maximize Coverage Leveraging BFS For Vaccines
Summary: This presentation from PDA vaccine conference by Bill Hartzel of Catalent Pharma Solutions focused on the use of the advanced aseptic filling techniques utilized in blow/fill/seal technology to enhance the global supply of vaccines through primary container design and manufacturing efficiency. It provided details and data on how the principles of BFS dramatically reduce the risk profile and particulate contamination in aseptic filling. In addition, the presentation provided information on the container closure and a case study of a model monoclonal antibody in a BFS vial compared to glass. Finally, it discussed primary container design freedom to help address the needs of vaccine distribution and delivery.